Analysts: Optimer Pharmaceuticals Inc (OPTR.OQ)

OPTR.OQ on NASDAQ Stock Exchange Global Select Market

12.48USD
1 Aug 2013
Price Change (% chg)

$-0.03 (-0.24%)
Prev Close
$12.51
Open
$12.64
Day's High
$12.65
Day's Low
$12.48
Volume
558,582
Avg. Vol
327,918
52-wk High
$16.77
52-wk Low
$8.66

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.54 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 4 4 5
(2) OUTPERFORM 0 1 1 2
(3) HOLD 7 5 5 3
(4) UNDERPERFORM 1 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.70 2.42 2.42 2.17

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 9 23.24 26.74 19.01 36.28
Quarter Ending Dec-13 9 25.60 30.29 18.91 39.41
Year Ending Dec-13 10 88.83 99.64 77.89 149.10
Year Ending Dec-14 9 137.03 170.30 92.12 198.66
Earnings (per share)
Quarter Ending Sep-13 9 -0.54 -0.46 -0.63 -0.32
Quarter Ending Dec-13 9 -0.51 -0.42 -0.63 -0.29
Year Ending Dec-13 10 -2.32 -2.15 -2.79 -1.21
Year Ending Dec-14 9 -1.05 0.18 -1.74 -0.04

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 21.09 19.43 1.65 7.83
Quarter Ending Dec-12 18.05 19.52 1.46 8.11
Quarter Ending Sep-12 16.03 17.88 1.85 11.52
Quarter Ending Jun-12 43.84 49.76 5.92 13.49
Quarter Ending Mar-12 28.77 14.38 14.39 50.01
Earnings (per share)
Quarter Ending Mar-13 -0.41 -0.65 0.23 -56.63
Quarter Ending Dec-12 -0.38 -0.64 0.26 -67.10
Quarter Ending Sep-12 -0.64 -0.56 0.08 -12.36
Quarter Ending Jun-12 -0.07 -0.01 0.06 -85.14
Quarter Ending Mar-12 -0.38 -0.71 0.33 -86.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 23.24 23.36 23.49 23.70 36.28
Quarter Ending Dec-13 25.60 25.81 26.03 26.34 39.41
Year Ending Dec-13 88.83 89.16 90.30 90.89 149.10
Year Ending Dec-14 137.03 138.21 140.06 139.81 198.66
Earnings (per share)
Quarter Ending Sep-13 -0.54 -0.52 -0.51 -0.51 -0.32
Quarter Ending Dec-13 -0.51 -0.50 -0.49 -0.48 -0.29
Quarter Ending Dec-13 -2.32 -2.29 -2.24 -2.23 -1.21
Quarter Ending Dec-14 -1.05 -1.02 -0.99 -0.99 -0.04

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 1 0 1
Quarter Ending Dec-13 0 1 0 1
Year Ending Dec-13 1 1 1 2
Year Ending Dec-14 0 1 0 2
Earnings
Quarter Ending Sep-13 0 1 0 1
Quarter Ending Dec-13 0 1 0 1
Year Ending Dec-13 0 1 1 2
Year Ending Dec-14 0 1 1 2

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks